戻る
Duality Biotherapeutics, Inc. (09606.HK)価格
09606.HK 株価推移チャート
DUALITYBIO-B (09606.HK)
Duality Biotherapeutics, Inc.
HK$347.4
-3.92%
$-14.2
休場: Jan 20, 16:00:00 HKT
主要データ
前終値
$355
始値
$361.6
当日レンジ
$344.4 - $370.8
52週レンジ
$165.5 - $563.5
取引高
645.3K
平均取引高
1.2M
1株当たり利益(TTM)
-35.78
配当利回り
--
時価総額
$30.5B
DUALITYBIO-Bとは何ですか？
Duality Biotherapeutics, Inc. operates as a clinical stage company. The company is headquartered in Shanghai, Shanghai and currently employs 191 full-time employees. The company went IPO on 2025-04-15. The firm is dedicated to the development of antibody-drug conjugate (ADC) innovative therapeutics to treat cancer and autoimmune diseases. The firm's primary drug product candidates include DB-1303/BNT323, DB-1311/BNT324, DB-1310, DB-1305/BNT325, DB-1419 and DB-2304. The firm's products are mainly used for the targeted treatment of endometrial cancer (EC), breast cancer (BC), small-cell lung cancer (SCLC), castration-resistant prostate cancer (CRPC), esophageal squamous cell carcinoma (ESCC), as well as head and neck squamous cell carcinoma (HNSCC). The firm principally conducts its businesses in domestic and overseas markets.
